Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

Clinical trial NCT02435849 · COMPLETED

Trial details

NCT number: NCT02435849
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2015-04-08
Primary completion: 2020-01-21
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.